CALYPTE BIOMEDICAL CORP Operating Income
CALYPTE BIOMEDICAL CORP reported Operating Income of -$955.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-06-24.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2014-06-24
- CALYPTE BIOMEDICAL CORP operating income (loss) for the quarter ending 2012-12-31 was -$259.00K.
- CALYPTE BIOMEDICAL CORP operating income (loss) for the quarter ending 2012-09-30 was -$233.00K.
- CALYPTE BIOMEDICAL CORP operating income (loss) for the quarter ending 2012-06-30 was -$206.00K.
- CALYPTE BIOMEDICAL CORP operating income (loss) for the quarter ending 2012-03-31 was -$258.00K.
- CALYPTE BIOMEDICAL CORP operating income (loss) for fiscal 2012 was -$955.00K.
- CALYPTE BIOMEDICAL CORP operating income (loss) for fiscal 2011 was -$973.00K.
- CALYPTE BIOMEDICAL CORP operating income (loss) for fiscal 2010 was -$1.10M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2012-12-31 | -$259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | -$492.00K derived: sum of 2 quarters · filed 2014-06-24 | -$698.00K derived: sum of 3 quarters · filed 2014-06-24 | -$955.00K 10-K · filed 2014-06-24 |
| 2012-09-30 | -$233.00K 10-Q · filed 2012-12-31 | -$439.00K derived: sum of 2 quarters · filed 2012-12-31 | -$696.00K 10-Q · filed 2012-12-31 | -$927.00K derived: sum of 4 quarters · filed 2014-06-24 |
| 2012-06-30 | -$206.00K 10-Q · filed 2012-08-14 | -$463.00K 10-Q · filed 2012-08-14 | -$694.00K derived: sum of 3 quarters · filed 2014-06-24 | -$912.00K derived: sum of 4 quarters · filed 2014-06-24 |
| 2012-03-31 | -$258.00K 10-Q · filed 2012-05-15 | -$488.00K derived: sum of 2 quarters · filed 2014-06-24 | -$706.00K derived: sum of 3 quarters · filed 2014-06-24 | -$992.00K derived: sum of 4 quarters · filed 2014-06-24 |
| 2011-12-31 | -$230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | -$448.00K derived: sum of 2 quarters · filed 2014-06-24 | -$734.00K derived: sum of 3 quarters · filed 2014-06-24 | -$973.00K 10-K · filed 2014-06-24 |
| 2011-09-30 | -$218.00K 10-Q · filed 2012-12-31 | -$504.00K derived: sum of 2 quarters · filed 2012-12-31 | -$743.00K 10-Q · filed 2012-12-31 | -$1.06M derived: sum of 4 quarters · filed 2012-12-31 |
| 2011-06-30 | -$286.00K 10-Q · filed 2012-08-14 | -$525.00K 10-Q · filed 2012-08-14 | -$847.00K derived: sum of 3 quarters · filed 2012-08-14 | -$1.12M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | -$240.00K 10-Q · filed 2012-05-15 | -$561.00K derived: sum of 2 quarters · filed 2012-05-15 | -$836.00K derived: sum of 3 quarters · filed 2012-05-15 | -$1.06M derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | -$321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | -$596.00K derived: sum of 2 quarters · filed 2012-03-22 | -$823.00K derived: sum of 3 quarters · filed 2012-03-22 | -$1.10M 10-K · filed 2012-03-22 |
| 2010-09-30 | -$275.00K 10-Q · filed 2012-01-27 | -$502.00K derived: sum of 2 quarters · filed 2012-01-27 | -$776.00K 10-Q · filed 2012-01-27 | |
| 2010-06-30 | -$227.00K 10-Q/A · filed 2011-11-30 | -$500.00K 10-Q/A · filed 2011-11-30 |